1.13. Analysis.
Comparison 1 Cholinesterase inhibitor (optimum dose) vs placebo, Outcome 13 Number who suffered at least one adverse event of abdominal pain before end of treatment at 6 months or later.
Comparison 1 Cholinesterase inhibitor (optimum dose) vs placebo, Outcome 13 Number who suffered at least one adverse event of abdominal pain before end of treatment at 6 months or later.